Using 18F-Fluorodeoxyglucose Positron Emission Tomography to Estimate the Length of Gross Tumor in Patients With Squamous Cell Carcinoma of the Esophagus
Creators
- 1. Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Jinan (China)
- 2. Department of Radiation Oncology, Tianjin Medical University Cancer Hospital and Institute, Tianjin (China)
- 3. Department of Thoracic Surgery, Shandong Cancer Hospital and Institute, Jinan (China)
- 4. Department of Pathology, Shandong Cancer Hospital and Institute, Jinan (China)
- 5. Department of Nuclear Medicine, Shandong Cancer Hospital and Institute, Jinan (China)
- 6. Sino-American Network for Therapeutic Radiology and Oncology, and Department of Radiation Oncology, University of Michigan, Ann Arbor, MI (United States)
Description
Purpose: To determine the optimal method of using 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) to estimate gross tumor length in esophageal carcinoma. Methods and Materials: Thirty-six patients with esophageal squamous cell carcinoma treated with radical surgery were enrolled. Gross tumor volumes (GTVs) were delineated using three different methods: visual interpretation, standardized uptake value (SUV) 2.5, and 40% of maximum standard uptake value (SUVmax) on FDG-PET imaging. The length of tumors on PET scan were measured and recorded as Lengthvis, Length2.5, and Length40, respectively, and compared with the length of gross tumor in the resected specimen (Lengthgross). All PET data were reviewed again postoperatively, and the GTV was delineated using various percentages of SUVmax. The optimal-threshold SUV was generated when the length of PET matched the Lengthgross. Results: The mean (±SD) Lengthgross was 5.48 ± 1.98 cm. The mean Lengthvis, Length2.5, and Length40 were 5.18 ± 1.93 cm, 5.49 ± 1.79 cm, and 4.34 ± 1.54 cm, respectively. The mean Lengthvis (p = 0.123) and Length2.5 (p = 0.957) were not significantly different from Lengthgross, and Length2.5 seems more approximate to Lengthgross. The mean Length40 was significantly shorter than Lengthgross (p < 0.001). The mean optimal threshold was 23.81% ± 11.29% for all tumors, and it was 19.78% ± 8.59%, 30.92% ± 12.28% for tumors ≥5 cm, and <5 cm, respectively (p = 0.009). The correlation coefficients of the optimal threshold were -0.802 and -0.561 with SUVmax and Lengthgross, respectively. Conclusions: The optimal PET method to estimate the length of gross tumor varies with tumor length and SUVmax; an SUV cutoff of 2.5 provided the closest estimation in this study
Availability note (English)
Available from http://dx.doi.org/10.1016/j.ijrobp.2008.04.015Additional details
Identifiers
- DOI
- 10.1016/j.ijrobp.2008.04.015;
- PII
- S0360-3016(08)00657-3;
Publishing Information
- Journal Title
- International Journal of Radiation Oncology, Biology and Physics
- Journal Volume
- 73
- Journal Issue
- 1
- Journal Page Range
- p. 136-141
- ISSN
- 0360-3016
- CODEN
- IOBPD3
INIS
- Country of Publication
- United States
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 40047723
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- CARCINOMAS; ESOPHAGUS; FLUORINE 18; FLUORODEOXYGLUCOSE; PATIENTS; POSITRON COMPUTED TOMOGRAPHY; RADIOTHERAPY; SURGERY; UPTAKE
- Descriptors DEC
- ANTIMETABOLITES; BETA DECAY RADIOISOTOPES; BETA-PLUS DECAY RADIOISOTOPES; BODY; COMPUTERIZED TOMOGRAPHY; DIAGNOSTIC TECHNIQUES; DIGESTIVE SYSTEM; DISEASES; DRUGS; EMISSION COMPUTED TOMOGRAPHY; FLUORINE ISOTOPES; HOURS LIVING RADIOISOTOPES; ISOMERIC TRANSITION ISOTOPES; ISOTOPES; LIGHT NUCLEI; MEDICINE; NANOSECONDS LIVING RADIOISOTOPES; NEOPLASMS; NUCLEAR MEDICINE; NUCLEI; ODD-ODD NUCLEI; ORGANS; RADIOISOTOPES; RADIOLOGY; THERAPY; TOMOGRAPHY
Optional Information
- Copyright
- Copyright (c) 2009 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.